Should Siblings Get Genetic Testing for Early Puberty?

If your oldest daughter has a confirmed genetic mutation (a pathogenic variant) for central precocious puberty, you might be wondering if your younger daughters need to be tested. The short answer is that predictive genetic testing is an option, but not a strict requirement.

The decision depends on confirming the exact genetic variant, determining which parent passed it down, and discussing the pros and cons with your pediatric endocrinologist or a genetic counselor. Regardless of whether you choose to test their genetics, routine clinical monitoring of your younger daughters’ growth and development is essential.

Inheritance Risk vs. Early Puberty Risk

The most common genes associated with familial central precocious puberty are MKRN3 and DLK1. These genes follow a unique inheritance pattern known as maternal imprinting ^[1]. This means the gene’s effect on puberty depends entirely on which parent it came from.

• If the father carries the pathogenic variant: He has a 50% chance of passing it to each of his children. However, a 50% chance of inheriting the variant does not equal a 100% chance of early puberty. It simply means the child has an increased risk of developing the condition ^[2][3]. Keep in mind that a father can carry the variant even if he did not obviously go through early puberty himself, as the signs in boys can be variable or unrecognized ^[4][5].
• If the mother carries the pathogenic variant: She also has a 50% chance of passing it to her children. But because of maternal imprinting, the copy inherited from the mother is naturally “silenced” or turned off. A child who inherits the variant from their mother will typically not develop early puberty from this variant, though they will be a carrier ^[4][2].

Because of this pattern, the first step is usually to test both parents to determine where the oldest daughter’s variant came from ^[1].

Clinical Monitoring: What to Watch For

Current endocrine guidelines do not mandate predictive genetic testing for asymptomatic siblings ^[6]. Whether you test or not, routine monitoring with your pediatrician is the most important step ^[7].

For girls, precocious puberty is defined by signs appearing before age 8. During regular checkups, your doctor will monitor:

• Breast development: The appearance of firm breast buds under the nipple is typically the first physical sign of central puberty ^[8].
• Rapid growth spurts: An unexpected, rapid increase in height (linear growth velocity) compared to their peers ^[7].
• Other signs: The development of pubic hair, body odor, or early acne can reflect early adrenal gland activity (adrenarche) rather than central puberty.

These other signs do not necessarily mean central precocious puberty has begun, but any new or progressive signs should be discussed with your pediatrician. If progressive signs appear before age 8, your doctor will likely refer you to a pediatric endocrinologist for an individualized evaluation, which may include hormone tests or a bone age X-ray.

Why Might a Doctor Discuss Predictive Testing?

A pediatric endocrinologist or genetic counselor might discuss testing your younger daughters before any physical signs appear ^[9]. This might be considered to:

• Inform imaging decisions: When a child begins early puberty, doctors often order a brain MRI to check for other causes. An MRI is a non-invasive imaging test that sometimes requires sedation in young children. While a known genetic variant does not automatically mean you can skip the MRI, it is a factor your doctor will consider alongside the child’s age, symptoms, and exam findings when making an individualized imaging plan ^[10][11].
• Tailor metabolic monitoring: If your family carries a pathogenic variant in the DLK1 gene, predictive testing may be valuable. DLK1 variants are associated with an increased risk for childhood obesity, elevated cholesterol, or insulin problems ^[12][13]. Not every carrier develops these issues, but knowing a child has the variant allows doctors to appropriately monitor their metabolism and weight trajectory over time.
• Prepare for potential treatment: Knowing a child carries the variant can help families know what to look for. However, carrying the variant alone is not a reason to start treatment. If progressive early puberty is confirmed through clinical exams and tests, doctors may discuss using puberty-blocking medications (GnRH agonists) to pause puberty ^[14]. This treatment is not automatic; the decision is always based on the individual child’s growth pace, bone age, and expected adult height.

Deciding whether to test asymptomatic children involves shared decision-making. You will want to weigh the reassurance of knowing against the potential anxiety of a positive result ^[6][15]. Your pediatric endocrinologist or a genetic counselor can help guide your family through testing options, privacy considerations, and the right clinical monitoring plan.